News|Articles|June 4, 2024

Enhancing Infection Control in Long-Term Care Facilities: The Impact of Dry Hydrogen Peroxide

Dry hydrogen peroxide (DHP) significantly reduces surface bioburden in long-term care facilities, enhancing infection control and lowering volatile organic compounds, as presented by Mary L. Cole, MS, RN, CNRN, CCRN, SCRN, CIC, at APIC24.

Environmental infection transmission is a perennial problem in long-term care facilities (LTCFs). In LTCFs, managing environmental infection transmission is a complex and ongoing challenge. Factors such as shared living spaces, cognitive impairments among residents, staffing shortages, and less-than-optimal cleaning practices contribute to the persistence of this issue.

A study recently evaluated the impact of dry hydrogen peroxide (DHP) as a supplement to manual decontamination on bioburden within an LTCF neurobehavioral unit. Mary L. Cole, MS, RN, CNRN, CCRN, SCRN, CIC, infection control specialist and project manager at The Highlands at Brighton, presented the study's results in a poster at the 2024 Association for Professionals in Infection Control and Epidemiology (APIC) 2024 Annual Conference & Exposition (APIC24) held from June 3 to 5 in San Antonio, Texas.

The study was a prospective environmental cohort study conducted in a 15-bed neurobehavioral unit within an LTCF. A total of 264 surface microbial samples were collected from 8 patient rooms and 2 communal areas at 3 different time points: before DHP deployment and on days 14, 28, and 55 post-DHP deployment. The objective was to measure the reduction in bioburden, characterized by total colony-forming units (CFUs) at each sampling site, before and after the deployment of DHP.

Additionally, volatile organic compound (VOC) levels were measured in each patient area on all sampling dates. Multivariate regression was used to analyze microbial reductions associated with DHP exposure, controlling for sample and treatment sites.

The study found a statistically significant relationship between DHP exposure and surface microbial load reduction (P < 0.00001). Postintervention, the average VOC levels in patient areas were significantly lower than baseline levels (P = 0.0031). These findings indicate that DHP can reduce surface bioburden in occupied spaces, enhancing infection prevention and control efforts in LTCFs.

The deployment of DHP in the neurobehavioral unit of an LTCF significantly reduced the surface bioburden, highlighting its potential as an effective supplement to traditional manual decontamination methods. By lowering the microbial load on surfaces, DHP can play a crucial role in infection prevention and control, particularly in environments with vulnerable populations such as those in LTCFs.

The results of this study are significant for infection preventionists working in LTCFs. The ability to significantly reduce surface bioburden using DHP presents a valuable tool in the ongoing battle against health care-associated infections. This method offers a proactive approach to managing infection risks, particularly in facilities with high-risk populations and challenging environments.

Moreover, the study's findings on reducing VOC levels post-DHP deployment add another layer of benefit, as lower VOC levels contribute to healthier indoor air quality, which is essential in maintaining overall resident health and comfort.

Incorporating DHP into the infection control protocols of LTCFs could be a game-changer. This study demonstrates the efficacy of DHP in reducing surface bioburden. It underscores the importance of innovative approaches in enhancing the safety and well-being of residents in long-term care settings. As we continue to navigate the complexities of infection control, embracing such advancements will be crucial in safeguarding our most vulnerable populations.


Related to this article

Dyan Troxell, MSN, RN, director of clinical education at HandCraft Linen Services; J.J. Odom, MBA, CHESP, CMIP, T-CHEST, university director of buildings and grounds for UConn Health and chair-elect of the AHE Board; and Jenna Rivers, MPH, CPH, CIC, manager of infection prevention and control at Moffitt Cancer Center in Tampa, Florida.
At AHE Exchange 2026, ICT spoke with experts representing commercial laundry services, EVS, and infection prevention about the systems behind a successful reusable linen program. They discuss linen quality, reject rates, unnecessary waste, frontline education, data, PAR levels, infection prevention oversight, and why strong relationships between health care facilities and their laundry providers matter.
Sadé L. Rolon, MBA, CMIP, CHESP, T-CHEST, T-CSCT, the regional director of operations for Sodexo’s Healthcare Division,  Julie Mangino, MD, infectious disease specialist at The Ohio State University Medical Center, Columbus, OH,  James “JJ” Odom, MBA, CHESP, CMIP, T-CHEST, the university director of buildings & grounds at UConn Health, Farmington, Connecticut,  Christopher Dugard, MS, director for the Division of Infection Control Devices in the Office of Surgical and Infection Control Devices, FDA/Center for Devices and Radiological Health.  and Elizabeth “Liz” Claverie, MS, (retired CAPT, 0-6) vice president, regulatory strategic liaison for Steris.  (Image credit: Author)
Can a UV-C robot make up for a surface that wasn't properly cleaned? Experts say that's the wrong way to think about the technology. UV-C can provide an additional layer of microbial reduction, but factors including shadows, distance, positioning, and exposure time mean it cannot replace thorough manual cleaning and disinfection.
Sadé L. Rolon, MBA, CMIP, CHESP, T-CHEST, T-CSCT, the regional director of operations for Sodexo’s Healthcare Division,  Julie Mangino, MD, infectious disease specialist at The Ohio State University Medical Center, Columbus, OH,  James “JJ” Odom, MBA, CHESP, CMIP, T-CHEST, the university director of buildings & grounds at UConn Health, Farmington, Connecticut,  Christopher Dugard, MS, director for the Division of Infection Control Devices in the Office of Surgical and Infection Control Devices, FDA/Center for Devices and Radiological Health.  and Elizabeth “Liz” Claverie, MS, (retired CAPT, 0-6) vice president, regulatory strategic liaison for Steris.  (Image credit: Author)
During an expert panel at Exchange26 on whole-room microbial reduction technologies, regulatory and health care leaders discussed the distinction between FDA and EPA oversight, what constitutes a medical device claim, the risks surrounding unauthorized or off-label claims, and why IP and EVS professionals should verify a device's regulatory status rather than relying solely on vendor presentations.
Donald Sipp, Jr, MBA, RESE, CHESP, CHTI-2, CMIP, PMP, and David Green  (Image credit: author)
“Cutting” waste shouldn’t mean cutting people. At AHE Exchange26, David Green and Donald Sipp explored how EVS departments can improve performance by strengthening workplace culture, empowering employees, eliminating inefficient processes, and understanding EVS’s critical role in patient throughput. One case study showed bed turnaround times falling from nearly 2 hours to less than an hour, but the larger lesson wasn't simply about speed. High-performing EVS operations begin with a strong foundation.